使用ELUVIA紫杉醇洗脱支架治疗股浅动脉的病理记录 - Suppr

Suppr

超能文献

Pathography of Superficial Femoral Artery Treated With ELUVIA Paclitaxel Eluting Stent.

作者信息

Matsumoto Yuki, Torii Sho, Morino Yoshihiro

机构信息

Department of Cardiology, Iwate Prefectural Kuji Hospital.

Department of Cardiology, Tokai University School of Medicine.

出版信息

Circ J. 2022 May 25;86(6):1021. doi: 10.1253/circj.CJ-21-0984. Epub 2022 Jan 6.

DOI:10.1253/circj.CJ-21-0984

PMID:34987142

Abstract

摘要

相似文献

Pathography of Superficial Femoral Artery Treated With ELUVIA Paclitaxel Eluting Stent.使用ELUVIA紫杉醇洗脱支架治疗股浅动脉的病理记录

Circ J. 2022 May 25;86(6):1021. doi: 10.1253/circj.CJ-21-0984. Epub 2022 Jan 6.

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.Eluvia紫杉醇洗脱支架治疗股腘动脉闭塞性疾病的MAJESTIC试验的12个月结果。

J Endovasc Ther. 2016 Oct;23(5):701-7. doi: 10.1177/1526602816650206. Epub 2016 May 18.

A polymer-coated, paclitaxel-eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomised, non-inferiority trial.聚合物涂层紫杉醇洗脱支架（Eluvia）与无聚合物紫杉醇涂层支架（Zilver PTX）治疗下肢股腘动脉腔内介入治疗（IMPERIAL）：一项随机非劣效试验。

Lancet. 2018 Oct 27;392(10157):1541-1551. doi: 10.1016/S0140-6736(18)32262-1. Epub 2018 Sep 24.

1-Year All-Comers Analysis of the Eluvia Drug-Eluting Stent for Long Femoropopliteal Lesions After Suboptimal Angioplasty.1 年所有入组患者分析：在次优球囊成形术后长段股浅动脉病变中使用 Eluvia 药物洗脱支架。

JACC Cardiovasc Interv. 2018 May 28;11(10):957-966. doi: 10.1016/j.jcin.2018.03.046.

Creep of Calcium Nodules Through Struts of Paclitaxel-Eluting Stent in Distal Superficial Femoral Artery.

Circ J. 2023 Aug 25;87(9):1249. doi: 10.1253/circj.CJ-23-0384. Epub 2023 Aug 1.

Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents.日本患者在 IMPERIAL 随机试验中接受 Eluvia 和 Zilver PTX 支架治疗。

Cardiovasc Intervent Radiol. 2020 Feb;43(2):215-222. doi: 10.1007/s00270-019-02355-x. Epub 2019 Nov 5.

Strut Coverage After Paclitaxel-Eluting Stent Implantation in the Superficial Femoral Artery.

JACC Cardiovasc Imaging. 2016 Jun;9(6):753-5. doi: 10.1016/j.jcmg.2015.05.007. Epub 2015 Aug 19.

Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.紫杉醇洗脱球囊与标准球囊血管成形术治疗股浅动脉和腘动脉支架内再狭窄：PACUBA 试验 1 年结果。

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1386-92. doi: 10.1016/j.jcin.2016.04.012.

Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study of the Eluvia Polymer-Coated Drug-Eluting Stent and the Zilver PTX Polymer-free Drug-Coated Stent.来自 IMPERIAL 随机研究的 Eluvia 聚合物涂层药物洗脱支架和 Zilver PTX 无聚合物涂层药物洗脱支架的两年疗效和安全性结果。

Cardiovasc Intervent Radiol. 2021 Mar;44(3):368-375. doi: 10.1007/s00270-020-02693-1. Epub 2020 Nov 22.

Cost-effectiveness of a paclitaxel-eluting stent (Eluvia) compared to Zilver PTX for endovascular femoropopliteal intervention.紫杉醇洗脱支架（Eluvia）与 Zilver PTX 用于血管内股腘动脉介入治疗的成本效益比较。

J Med Econ. 2022 Jan-Dec;25(1):880-887. doi: 10.1080/13696998.2022.2088965.

引用本文的文献

and pathography: Their commonalities and differences.以及病理记录：它们的共性与差异。

PCN Rep. 2025 Apr 21;4(2):e70102. doi: 10.1002/pcn5.70102. eCollection 2025 Jun.

The Endovascular Therapy for In-Stent Restenosis After Fluoropolymer-Based Drug-Eluting Stent Implantation in Femoropopliteal Lesions.基于含氟聚合物的药物洗脱支架植入治疗股腘病变后支架内再狭窄的血管内治疗

JACC Asia. 2025 Jan 7;5(1):119-121. doi: 10.1016/j.jacasi.2024.10.023. eCollection 2025 Jan.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验